PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE

Eplerenone (Inspra, Pfizer) improves the prognosis of patients with chronic heart failure and heart failure after acute myocardial infarction. Since Russia eplerenone pharmacoeconomics issues rarely discussed, the analysis of the literature on this topic was performed. 2 studies examined effects of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. M. Lopatin, E. Yu. Lopatina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2015-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	pharmacoeconomics eplerenone heart failure myocardial infarction
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/251
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Prospective Crossover Clinical Trial of Esaxerenone and Eplerenone in Patients with Chronic Heart Failure Complicated by Hypertension
by: Akira Sezai, et al.
Published: (2025-05-01)

New Clinical Aspects of Eplerenone Use in Clinical Practice
by: S. R. Gilyarevskiy, et al.
Published: (2018-09-01)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015-09-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

The effectiveness of eplerenone in clinical practice from the standpoint of evidence-based medicine (twenty years on the guard of life)
by: A. G. Evdokimova, et al.
Published: (2023-01-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)

The The Impact of Dapagliflozin on Aldosterone Hormone in Rats with Heart Failure
by: Skala Mamand Jawhar, et al.
Published: (2023-09-01)

EVIDENCE-BASED USE OF EPLERENONE
by: S. R. Gilyarevski, et al.
Published: (2014-07-01)

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

The use of mineralocorticoid antagonists in chronic heart failure
by: Andrea Szegedi, et al.
Published: (2025-07-01)

Influence of combined eplerenone, aflibercept and nepafenac therapy on central serous chorioretinopathy
by: Wael Ahmed Ewais, et al.
Published: (2025-06-01)

Chronic heart failure
by: J. A. Ker
Published: (2015-09-01)

Comorbidity in acute heart failure complicating myocardial infarction
by: M. V. Zykov, et al.
Published: (2020-08-01)

The role of free radical oxidation in the kidneys in the nephroprotective action of eplerenone, a mineralocorticoid receptor antagonist, in experimental diabetes mellitus
by: A. Yu. Zharikov, et al.
Published: (2021-07-01)

Predictors of acute heart failure in patients during the acute period of Q-wave myocardial infarction
by: V. D. Syvolap, et al.
Published: (2019-04-01)

Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome
by: O. A. Osipova, et al.
Published: (2022-07-01)

Short-term and long-term prognosis in patients with Q-myocardial infarction complicated by acute heart failure with hyperglycemia
by: V. D. Syvolap, et al.
Published: (2019-10-01)

Pharmacoeconomic evaluation of aspirin therapy in pharmaceutical prevention of the first acute myocardial infarction in patients with stable angina
by: A. Yu. Kulikov, et al.
Published: (2010-02-01)

Postpartum administration of eplerenone to mitigate vascular dysfunction in mice following a preeclampsia-like pregnancy
by: Natalie K. Binder, et al.
Published: (2025-05-01)

HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY
by: V. V. Mazur, et al.
Published: (2016-01-01)

The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study
by: Alexey A. Nekrasov, et al.
Published: (2019-10-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

CLINICAL AND ULTRASOUND PREDICTORS OF HEART FAILURE DEVELOPMENT IN PATIENTS WITH SUBACUTE MYOCARDIAL INFARCTION
by: D. Yu. Serdyukov, et al.
Published: (2012-04-01)

Cardiac remodeling in the acute period of Q-myocardial infarction, complicated by acute heart failure and hyperglycemia
by: V. D. Syvolap, et al.
Published: (2019-05-01)

Formulation and Characterization of Eplerenone Nanocrystal as Sublingual Fast-dissolving Film
by: Hawraa Kareem, et al.
Published: (2024-12-01)

Prognostic value of GDF levels 15 and NTproBNP and echocardiographic parameters in patients with heart failure with preserved ejection fraction, after myocardial infarction on the background of hypertension according to the three-year observation
by: V. D. Syvolap, et al.
Published: (2015-10-01)

A PREDICTION MODEL FOR CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: Mariia Yu. Koteliukh, et al.
Published: (2025-04-01)

PLACE OF VOLUMETRIC LOAD IN ASSESSMENT OF DIASTOLIC RESERVE OF THE LEFT VENTRICLE AND IN PREDICTION OF HEART FAILURE DEVELOPMENT FOR MYOCARDIAL INFARCTION PATIENTS
by: M. T. Beyshenkulov, et al.
Published: (2016-08-01)

Beta-adrenergic reactivity of erythrocytes and the progression of heart failure in patients after myocardial infarction
by: A. A. Garganeeva, et al.
Published: (2020-02-01)

The role of the cardiac lymphatic system in the development and progression of heart failure and novel therapeutic approaches for its management in post-infarction cardiac remodeling
by: Yu. S. Korneva, et al.
Published: (2020-07-01)

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01)

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease
by: E. I. Tarlovskaya, et al.
Published: (2016-03-01)

Heart failure and anemia in patients with acute myocardial infarction
by: T. Yu. Kalyuta, et al.
Published: (2005-02-01)

Risk of myocardial infarction and heart failure in gout patients: a systematic review and meta-analysis
by: Panpan Wang, et al.
Published: (2025-01-01)

Myocardial electrical activity according to daily ECG monitoring in patients with heart failure with preserved ejection fraction and asymptomatic diastolic dysfunction
by: V. D. Syvolap, et al.
Published: (2016-01-01)

Effect of constipation on hospitalization due to heart failure in patients after myocardial infarction: a retrospective cohort study
by: Shigeto Namiuchi, et al.
Published: (2025-05-01)

Bibliometric study and visualization of myocardial infarction combined with heart failure, 1993–2023
by: Kexin Wang, et al.
Published: (2025-08-01)

Pharmacoeconomic aspects of COVID-19 treatment
by: I. V. Rogova, et al.
Published: (2021-10-01)

Predictors of stress hyperglycemia in patients with acute phase of Q-wave myocardial infarction complicated by acute heart failure without diabetes history
by: N. I. Kapshytar, et al.
Published: (2018-06-01)

«CLASS OF EVIDENCE IIB» FOR ACUTE HEART FAILURE: WHEN, WHO, WHY?
by: A. M. Namitokov, et al.
Published: (2019-02-01)